Dear Stervc,

I came across a post that really confuses me. See post #48520. In that post it shows that Iequity has major interests in several MMJ companies:

Cannabis Creative Partners, Inc

CBD Drink

CoKasper Seeding

Medical Cannabis Venture Corp

Medical Greens

MedScience Laboratories

PharmaJanes

Simple Prepay

SK3 Group, Inc

World Pharma Financial

From the looks of things SK3 Group is a sub of Iequity and they are not the major integrator. Can you enlighten me as to which "mothership" is bringing the whole picture together?

It doesn't seem SK3 Group is the major player.

PPS Going Up.

Bid and ask above the last printed price.

Strong bid at 1,000, 000

200 share sell to shake up; didn't work.

Not at all.

Take a look at PPTO. New tech has become available where fracing does not have to be performed.

On comes HDogtx as a mod to the PPTO board. Heavey hitter. Lots of followers. Price/volume instantly pops. That board comes alive.

THAT CAN EASILY HAPPEN HERE.

Today's price goes down on a 200 share sell. It sold at $.40 for an $80.00 trade. A price drop of 20% on an $80.00 trade. Meaningless. Except some entity is trying to trigger an unsuspecting stop loss. That entity can then grab those shares that cascaded. However, it didn't work. Could also be that someone needed $80.00 to buy PPTO.

Oh. It wasn't a MM doing it either. They really could care less.

So don't fret. Things can happen.

Doubt any dilution. It would also dilute the corp officer's equity % also.
They appear to have "enough cash flow" per their last filing, but was NOT the amounts claimed in their pr's.

Still, I don't see any dilution in the foreseable future.

Just in time for Lanshe's founding, father's stock to become unrestricted (6 month holding requirement).

Expect NTRO stock to come alive then.

Don't really need to. La Mesa is a very ritzy section of San Diego. That whole area has alot of biotech R&D facilites.

All the info I have is from the SEC filings, pr's, published literature on Hemexelerate as well as the researchers. I can't do any better by visiting the facility.

Yes, they are resticted. They are required to hold for 6+ months min. They are digging in on a risky sub penny stock with no real ave of escape. They have to be dug in.

If I were to invest hundreds of thousands of $ I would, at a min, visit the BioMatrix facility in La Mesa, Ca and ask for a tour. A big whale would surely be granted that request.
I would be peeking, probing and "spying". Something has to be gotten from Koos. Ask a question to Koos and get a frown or a smile and I'd get plenty of info.

They look like they are in for investment purposes and not flipping.

Does look like a buy since an uptick in price occurred.

Yes, they are restricted shares. Must wait 6 months or 12 months depending on whether they were after or before the uplisting respectively.

Highly doubt his post.

There could be lots of reasons a stock can be halted (again it was not). Securities violations say.

Just though ENTB was more liquid than what it was showing. Poised as a question instead of a definitive.

It's not halted.

ENTB finally got some volume.

That is not a new thing (meaning standard operating procedure). It is NOT a usual thing either. Not necessarily a bad thing either.

Well ENTB looks like it is halted. BMSN next?

Loa. Letter of agreement.

Also note "The Whale" kept well below the 13g radar nulling out the requirement of reporting the purchase and thus becoming a restricted stock. There was approx 1.3B shares back then. 5% would give 65M as a stop point.

Whale buys in for only 30M shares.

He'll be back on the dips. You can bank on that.

Peeps on board are paranoid about everything. There has been nary a word about a RS by BMSN.

BMSN can get a grant,say, to get funding like BCLI did/is/will from the Israeli govt.

I Read That PR As Calender Quarter, Not Fiscal.

It's hard to imangine the quibbling going on over this.

Absolutely. 100%

Sounds good. Venture capitalists also?

On The Reverse Split:

A simple RS does not change your equity position in BMSN;
you still have the same ownership %. If no dilution, nothing changes except BMSN's image as a non sub penny stock. It looks better to institutional investors.

If there is dilution for clinical trials, that is a very good dilution.
If done for GAO, less good. That is not progression though. If done for bonuses/salaries/stock issuances for corp officers/directors then it is bad (CTIC case in hand) dilution.

I can enumerate out many a company that did a RS and for the better.
The following co's did RS's and came out better:

C
AIG
BPOP

If Koos, I would possibly go with convertible notes or other stock derivatives.
With a note, you may have expanded negotiation capabilities.

RS, with dilution for clinical trials, is BMSN's best option.

Yes. Even after FDA approval, vis a vis clinical trials are finished, there is still post clinical followings for alot of years.

Wrong kind of volume to have.

Aren't they, called also a V (must like to use all V market makers also), required to wait six months? They got in, after the fact of the uplisting, so it appears they must wait the statutory time of 6 months.

Very Cheap Chintzy Promoters.

Koos would never resort to subversive, cheap promoters.

It is one of those 13g ers that made what they thought was a bad investment decision and wanted out.

Need to check with the TA daily to see if it is genuine dilution.

PROMOS can come at anytime by the BIG INVESTORS.

BMSN has NO control over what a hedge fund or institutional investor does, promotion wise.

Timeframe wise, it appears to be very fast.

Here's the panacea:


LICENSING/CO DEVELOPEMENT CAN BE EXPECTED 12 TO 18 MONTHS AFTER PHASE 1/2 CLINICAL TRIALS.

That puts the earliest licensing at 4 q 2014.

This could range to 6 months later or 2q 2015.

Here's the read I get from today's pr:

This is standard operating procedure, the FDA is moving forward, there is nothing deleterious or contentious about the approval

That is so funny. "Some moron" whacked the bid with a million share sell.

More like a "feces head".

Longs should realize you are making money now; you should be averaging down big time, hence making money.

The usual rule is NOT to average down on a penny stock. BMSN is the exception to the rule.

Psy Trader:

Selling short, you can only make 100% on your money.
Going long, I can make 10, 000% +. I have much more leverage than a shorter.

Stock issuance is the lifeblood of a start up company; shorting it's stock can kill it's lifeblood effectively crushing a company's growth capabilities.

With BMSN, the amount of items going positive for them makes it better to go long, especially with the investment odds in my favor.

BMSN IS NOT WORTHY OF BEING SHORTED.

Here's the candlestick analysis from Stockta.com:

How are you coming to this conclusion?

Any solid foundation?

Sure can happen if retailers are allowed to "Free Market".

By looking at the trades alone it is seen that alot of 10, 000 block sells took place.
That's a series of $39.00 trades. Strictly a ploy to drive the pps down.


Now look. The 9999 block share buys coming in. All greens. A ploy to drive pps up? Again, it's only a $39.00 buy.


MANIPULATION.

Just added a little.

Here's my proof




Time is EDT.

It was a slap at the ASK.

Buy on the upticks. If the stock is going to go to zero, let it.
If it turns around ie strong inside bid, uptick is + then buy.

So many people probably have sell orders in at $.01. If it hits $.01 they want out. PERIOD. One should use a trailing limit order on both buys AND sells. If your brokerage firm doesn't allow trailing orders for pennies, you'll have to simulate it manually.

My philosophy is to never sell a stock going up.
Also never buy a stock going down.

The time required to hold these resticted securities is 6 months; hence the summer of 2013 is the esrliest they can be sold.

Here's the holding requirements as applicable in BMSN's case (fully reporting):

What Are the Conditions of Rule 144?

If you want to sell your restricted or control securities to the public, you can meet the applicable conditions set forth in Rule 144. The rule is not the exclusive means for selling restricted or control securities, but provides a "safe harbor" exemption to sellers. The rule's five conditions are summarized below:

Holding Period. Before you may sell any restricted securities in the marketplace, you must hold them for a certain period of time. If the company that issued the securities is a “reporting company” in that it is subject to the reporting requirements of the Securities Exchange Act of 1934, then you must hold the securities for at least six months. If the issuer of the securities is not subject to the reporting requirements, then you must hold the securities for at least one year. The relevant holding period begins when the securities were bought and fully paid for. The holding period only applies to restricted securities. Because securities acquired in the public market are not restricted, there is no holding period for an affiliate who purchases securities of the issuer in the marketplace. But the resale of an affiliate's shares as control securities is subject to the other conditions of the rule.Since BMSN is a reporting company, the following guideline applies from Rule 144: